US 10814007
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
granted A61KA61K45/06A61K47/549
Quick answer
US patent 10814007 (Angiotensinogen (AGT) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K45/06, A61K47/549, A61P, A61P11/00